RACIAL AND ETHNIC DISPARITIES IN DIRECT-ACTING ANTIVIRAL (DAA) TREATMENT AND SURVIVAL OUTCOMES FOR TREATED/SVR (SUSTAINED VIROLOGIC RESPONSE) AND UNTREATED/NON-SVR PATIENTS WITH HEPATITIS C-RELATED HEPATOCELLULAR CARCINOMA (HCV-HCC): A REAL-HCC STUDY

被引：0
|
作者：
Park, Jung Eun
Nguyen, Vy H.
Tsai, Pei-Chien
Toyoda, Hidenori
Leong, Jennifer
Guy, Jennifer
Yeh, Ming-Lun
Huang, Chung-Feng
Yasuda, Satoshi
Abe, Hiroshi
Hsu, Yao-Chun
Tseng, Cheng-Hao
Liu, Joanne
Chen, Yao-Li
Lin, Ping-Yi
Jun, Dae Won
Yoshimaru, Yoko
Ogawa, Eiichi
Ishigami, Masatoshi
Enomoto, Masaru
Tamori, Akihiro
Uojima, Haruki
Wang, Xiao Zhong
Xu, Qiang
Takahashi, Hirokazu
Eguchi, Yuichiro
Inoue, Kaori
Huang, Daniel
Zhao, Wen Jing
Chuang, Wan-Long
Dai, Chia-Yen
Huang, Jee-Fu
Cheung, Ramsey
Landis, Charles
Tanaka, Yasuhito
Roberts, Lewis R.
Schwartz, Myron
Kumada, Takashi
Yu, Ming-Lung
Nguyen, Mindie H.
机构：
来源：
GASTROENTEROLOGY | 2023年 / 164卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
816
引用
收藏
页码：S1264 / S1265
页数：2
相关论文
共 25 条
  • [1] Impact of Hepatocellular Carcinoma (HCC) and Tumor Treatment on Sustained Virologic Response (SVR) Rates with Direct-Acting Antiviral (DAA) Therapy for Hepatitis C: HCV-TARGET Results
    Radhakrishnan, Kavita
    Di Bisceglie, Adrian M.
    Reddy, K. Rajender
    Lim, Joseph K.
    Levitsky, Josh
    Kuo, Alexander
    Hassan, Mohamed A.
    Darling, Jama M.
    Feld, Jordan J.
    Akushevich, Lucy
    Vainorius, Monika
    Nelson, David R.
    Fried, Michael W.
    Brown, Robert S.
    Terrault, Norah
    HEPATOLOGY, 2017, 66 : 755A - 756A
  • [2] RACIAL AND ETHNIC DISPARITIES IN CLINICAL PRESENTATION, TREATMENT, AND OVERALL SURVIVAL IN PATIENTS WITH HEPATITIS C-RELATED HEPATOCELLULAR CARCINOMA (HCV-HCC): A REAL-WORLD EXPERIENCE FROM THE REAL-HCC REGISTRY
    Park, Jung Eun
    Nguyen, Vy H.
    Tsai, Pei-Chien
    Toyoda, Hidenori
    Leong, Jennifer
    Guy, Jennifer E.
    Yeh, Ming-Lun
    Huang, Chung-Feng
    Yasuda, Satoshi
    Abe, Hiroshi
    Hsu, Yao-Chun
    Tseng, Cheng-Hao
    Liu, Joanne
    Chen, Yao-Li
    Lin, Ping-Yi
    Jun, Dae Won
    Yoshimaru, Yoko
    Ogawa, Eiichi
    Ishigami, Masatoshi
    Enomoto, Masaru
    Tamori, Akihiro
    Uojima, Haruki
    Wang, Xiao Zhong
    Xu, Qiang
    Takahashi, Hirokazu
    Eguchi, Yuichiro
    Inoue, Kaori
    Huang, Daniel
    Zhao, Wen Jing
    Chuang, Wan-Long
    Dai, Chia-Yen
    Huang, Jee-Fu
    Cheung, Ramsey
    Landis, Charles
    Tanaka, Yasuhito
    Roberts, Lewis R.
    Schwartz, Myron E.
    Kumada, Takashi
    Yu, Ming-Lung
    Nguyen, Mindie H.
    HEPATOLOGY, 2022, 76 : S403 - S405
  • [3] SUSTAINED VIROLOGIC RESPONSE (SVR) TO DIRECT-ACTING ANTIVIRAL (DAA) THERAPY IN PATIENTS WITH HEPATITIS C VIRUS (HCV) INFECTION AND HEPATOCELLULAR CARCINOMA (HCC): A SYSTEMATIC REVIEW AND META-ANALYSIS
    Ji, Fanpu
    Wei, Mike
    Yeo, Yee Hui
    Wei, Bin
    Ogawa, Eiichi
    Lee, Dong Hyun
    Enomoto, Masaru
    Toyoda, Hidenori
    Bass, Michelle B.
    Lubel, John
    Ide, Tatsuya
    Preda, Carmen Monica
    Iio, Etsuko
    Conti, Fabio
    Minami, Tatsuya
    Bielen, Rob
    Sezaki, Hitomi
    Barone, Michele
    Chu, Po-Sung
    Virlogeux, Victor
    Eurich, Dennis
    Kanai, Takanori
    Dang, Shuangsuo
    Li, Zongfang
    Furusyo, Norihiro
    Zoulim, Fabien
    Andreone, Pietro
    Cheung, Ramsey
    Tanaka, Yasuhito
    Tamori, Akihiro
    Nguyen, Mindie H.
    GASTROENTEROLOGY, 2018, 154 (06) : S1082 - S1083
  • [4] Sustained virologic response (SVR) to direct-acting antiviral (DAA) therapy in patients with chronic hepatitis C virus (HCV) infection and hepatocellular carcinoma (HCC): a systematic review and meta-analysis
    Ji, F.
    Wei, M. T.
    Yeo, Y. H.
    Wei, B.
    Ogawa, E.
    Lee, D. H.
    Enomoto, M.
    Toyoda, H.
    Bass, M. B.
    Lubel, J.
    Ide, T.
    Preda, C. M.
    Iio, E.
    Conti, F.
    Minami, T.
    Bielen, R.
    Sezaki, H.
    Barone, M.
    Chu, P. -S.
    Virlogeux, V.
    Eurich, D.
    Kanai, T.
    Dang, S.
    Li, Z.
    Furusyo, N.
    Zoulim, F.
    Andreone, P.
    Cheung, R. C.
    Tanaka, Y.
    Tamori, A.
    Nguyen, M.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S259 - S260
  • [5] SUSTAINED VIROLOGIC RESPONSE (SVR) IN HCV-INFECTED PATIENTS WITH HEPATOCELLULAR CARCINOMA ( HCC): REAL-WORLD OUTCOMES AND PREDICTORS OF SUCCESS
    Twitchell, David
    Bigham, Dakota
    Singleterry, Rodolfo
    Syed, Owais
    Tsai, Eugenia
    Rodas, Fabian
    Landaverde, Carmen
    Petrasek, Jan
    Lawitz, Eric
    Gomez-Aldana, Andres
    Pham, Emma
    Matthews, Amanda
    Ramos, Jamiel
    Velasquez, Kelly
    Caldera, Elizabeth
    Inskeep, Jonathan
    Vaughn, Clarissa
    Pedicone, Lisa
    Poordad, Fred
    HEPATOLOGY, 2024, 80 : S362 - S363
  • [6] Racial and ethnic disparities in untreated patients with hepatitis C virus-related hepatocellular carcinoma but not in those with sustained virologic response
    Park, Jung Eun
    Nguyen, Vy H.
    Tsai, Pei-Chien
    Toyoda, Hidenori
    Leong, Jennifer
    Guy, Jennifer E.
    Yeh, Ming-Lun
    Huang, Chung-Feng
    Yasuda, Satoshi
    Abe, Hiroshi
    Hsu, Yao-Chun
    Tseng, Cheng-Hao
    Liu, Joanne
    Chen, Yao-Li
    Lin, Ping-Yi
    Jun, Dae Won
    Yoshimaru, Yoko
    Ogawa, Eiichi
    Ishigami, Masatoshi
    Enomoto, Masaru
    Tamori, Akihiro
    Uojima, Haruki
    Wang, Xiao Zhong
    Xu, Qiang
    Takahashi, Hirokazu
    Eguchi, Yuichiro
    Inoue, Kaori
    Huang, Daniel Q.
    Zhao, Wen Jing
    Chuang, Wan-Long
    Dai, Chia-Yen
    Huang, Jee-Fu
    Barnett, Scott
    Maeda, Mayumi
    Cheung, Ramsey
    Landis, Charles
    Tanaka, Yasuhito
    Roberts, Lewis R.
    Schwartz, Myron E.
    Kumada, Takashi
    Yu, Ming-Lung
    Nguyen, Mindie H.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 59 (06) : 742 - 751
  • [7] COMPARISON OF SURVIVAL RATES BETWEEN DIRECT-ACTING ANTIVIRAL (DAA) THERAPY AND INTERFERON (IFN) THERAPY AFTER CURATIVE TREATMENT OF HEPATITIS C VIRUS (HCV)-RELATED HEPATOCELLULAR CARCINOMA (HCC)
    Joko, Kouji
    Mashiba, Toshie
    Ochi, Hironori
    Saneto, Hironobu
    Tabo, Yuri
    Sato, Kaori
    Aono, Michiko
    Azemoto, Nobuaki
    Yokota, Tomoyuki
    Tsuchiya, Kaoru
    Kurosaki, Masayuki
    Izumi, Namiki
    HEPATOLOGY, 2019, 70 : 209A - 209A
  • [8] IMPACT OF SUSTAINED VIROLOGIC RESPONSE (SVR) ON THE LIPID PROFILE AND CARDIOVASCULAR RISK OF PATIENTS INFECTED WITH CHRONIC HEPATITIS C VIRUS (HCV) TREATED WITH DIRECT-ACTING ANTIVIRALS (DAAS)
    Rafael Granados, Jose
    Serrano, Miriam
    Vega, Sara
    Mohamed, Karim
    Maria Robaina, Jose
    Maria Martin, Jose
    HEPATOLOGY, 2020, 72 : 534A - 535A
  • [9] RISK OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CHRONIC HEPATITIS C AND STAGE-3 LIVER FIBROSIS AFTER SUSTAINED VIROLOGICAL RESPONSE (SVR) WITH DIRECT-ACTING ANTIVIRALS (DAA)
    Sanchez-Azofra, Maria
    Fernandez, Inmaculada
    Luisa Garcia-Buey, Maria
    Dominguez, Lourdes
    Fernandez-Rodriguez, Conrado M.
    Moreno Planas, Jose Maria
    Bonet, Lucia
    Garcia Montes, Maria Luisa
    Ryan, Pablo
    Gea, Francisco
    Diaz Sanchez, Antonio
    Garcia-Mayor, Marian
    Luisa Manzano, Maria
    Gonzalez Moreno, Leticia
    Bisbal, Otilia
    Luisa Gutierrez, Maria
    Mancebo Martinez, Antonio
    Martin Carbonero, Luz
    Guerrero, Antonio
    Rivero, Miguel
    Elena Portales, Maria
    Castillo Grau, Pilar
    Olveira, Antonio
    HEPATOLOGY, 2020, 72 : 98A - 99A
  • [10] VFMAP predicted hepatocellular carcinoma development in patients with chronic hepatitis C who were treated with direct-acting antiviral and achieved sustained virologic response
    Matono, Tomomitsu
    Tada, Toshifumi
    Nishimura, Takashi
    Takashima, Tomoyuki
    Aizawa, Nobuhiro
    Ikeda, Naoto
    Shiomi, Hideyuki
    Enomoto, Hirayuki
    Iijima, Hiroko
    JOURNAL OF MEDICAL ULTRASONICS, 2024, 51 (02) : 293 - 300
123